Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Regeneron
Health
Sanofi
Disability
Diabetes
Cancer
Mental Health
Assisted Dying
Reproductive Health
Diet and Fitness
Heart Disease
Obesity
Topics

Advertisement

Advertisement

Regeneron

Share

Top Latest Popular

Sanofi and Regeneron expand immunology partnership to the tune of $8bn Pharmaceutical Technology 8d

Pharmaceutical Technology 8d

Moderna stock rises 2% on Nasdaq 100 entry but this analyst says sell Invezz 7d

Invezz 7d

Stock Market (US)

Uspto director issues opinion explaining denial of Biocon post-grant review petition (PGR) challenging eylea® patent JD Supra 7d

JD Supra 7d

Intellectual Property Pharma

Advertisement

Regeneron Eylea feels the pinch as Kodiak advances extended dosing for eye drug Benzinga 16:18 Mon, 28 Sep

Benzinga 16:18 Mon, 28 Sep

Stock Markets (World)

Regeneron beats investor suit over Medicare drug price reporting Bloomberg Law 19:40 Mon, 21 Sep

Bloomberg Law 19:40 Mon, 21 Sep

Credit Cards Pharma

Regeneron's ubamatamab, trevogrumab show strong results in Cancer and obesity studies RTT News 7d

RTT News 7d

Ovarian Cancer Ozempic

Advertisement

Advertisement

Latest

In the last 6 hours

Biohaven (BHVN), What Is Behind The Fresh Attention? Simply Wall St 20:08 Thu, 08 Oct

Tuesday

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026 Regeneron Pharmaceuticals (Press Release) 12:01 Tue, 06 Oct

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies Sanofi (Press Release) 06:38 Tue, 06 Oct

Sunday

Experimental Regeneron Antibody Trevogrumab Cut Lean Mass Loss by About 42% in Semaglutide Users Over One Year Medical Daily 09:46 Sun, 04 Oct

In the last month

Regeneron’s Myostatin Inhibitor Preserves Muscle Mass In Phase II Obesity Study Scrip Pharma Intelligence 22:40 Fri, 02 Oct

EASD 2026: Regeneron’s muscle preserver shows benefit at lower doses Clinical Trials Arena 16:25 Fri, 02 Oct

Moderna stock rises 2% on Nasdaq 100 entry but this analyst says sell Invezz 11:46 Fri, 02 Oct

Sanofi And Regeneron Rekindle Their Alliance, But Will Magic Strike Again? Scrip Pharma Intelligence 22:46 Thu, 01 Oct

Sanofi to ‘ignite’ R&D in $8B deal with longstanding partner Regeneron BioWorld 21:10 Thu, 01 Oct

USPTO Director Issues Opinion Explaining Denial of Biocon Post-Grant Review Petition (PGR) Challenging EYLEA® Patent JD Supra 20:27 Thu, 01 Oct

Advertisement

Advertisement

Advertisement

My Local News

Popular

Experimental Regeneron antibody trevogrumab cut lean mass loss by about 42% in semaglutide users over one year

Medical Daily 5d

Easd 2026: Regeneron’s muscle preserver shows benefit at lower doses

Clinical Trials Arena 6d

Sanofi And Regeneron Rekindle Their Alliance, But Will Magic Strike Again?

Scrip Pharma Intelligence 7d

Moderna stock falls 6% in premarket: here's why

Invezz 13:19 Wed, 30 Sep

Mirum’s atebrioz, first oral approved for fop, to face Regeneron’s pasatru

Scrip Pharma Intelligence 23:23 Fri, 25 Sep

Advertisement

Advertisement

Advertisement

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Health Health
Back to Lifestyle Health
- Diet and Fitness
- Mental Health
- Cancer Cancer
- Diabetes Diabetes
- Disability Disability
- Gastrointestinal Diseases
- Infectious Diseases
- Neurological Diseases
- Reproductive Health
- Sexual Health
- Allergies Allergies
- Alopecia Alopecia
- Antibiotic Resistance
- Assisted Dying
- Blood Disorders
- Heart Disease
- Obesity Obesity
- PTSD PTSD
- Rare Diseases
- SIDS SIDS